Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,200 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 5 August 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 187 pages)

 

Export 2296 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
V
E. L. Herrett, Thomas, S. L., and Smeeth, L., Validity of diagnoses in the general practice research database, Br J Gen Pract, vol. 61, pp. 438-9, 2011.
M. E. Saine, Gizaw, M., Carbonari, D. M., Newcomb, C. W., Roy, J. A., Cardillo, S., Esposito, D. B., Bhullar, H., Gallagher, A. M., Strom, B. L., and , Validity of diagnostic codes to identify hospitalizations for infections among patients treated with oral anti-diabetic drugs, Pharmacoepidemiol Drug Saf, 2017.
N. F. Khan, Harrison, S. E., and Rose, P. W., Validity of diagnostic coding within the General Practice Research Database: a systematic review, Br J Gen Pract, vol. 60, pp. e128-36, 2010.
M. Iwagami, Tomlinson, L. A., Mansfield, K. E., Casula, A., Caskey, F. J., Aitken, G., Fraser, S. D. S., Roderick, P. J., and Nitsch, D., Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom, Nephrol Dial Transplant, vol. 32, pp. ii142-ii150, 2017.
L. Li, Setoguchi, S., and Jick, S., Validity of non-fatal idiopathic serious ventricular arrhythmia in UK-based Clinical Practice Research Datalink, Pharmacoepidemiol Drug Saf, vol. 23, pp. 999-1001, 2014.
H. P. Booth, Prevost, A. T., and Gulliford, M. C., Validity of smoking prevalence estimates from primary care electronic health records compared with national population survey data for England, 2007 to 2011, Pharmacoepidemiol Drug Saf, vol. 22, pp. 1357-61, 2013.
S. S. Jick, Kaye, J. A., Vasilakis-Scaramozza, C., Rodriguez, L. A. Garcia, Ruigomez, A., Meier, C. R., Schlienger, R. G., Black, C., and Jick, H., Validity of the general practice research database, Pharmacotherapy, vol. 23, pp. 686-9, 2003.
S. F. Weng, Kai, J., Guha, I. N., and Qureshi, N., The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment, Open Heart, vol. 2, p. e000272, 2015.
A. V. Margulis, Fortuny, J., Kaye, J. A., Calingaert, B., Reynolds, M., Plana, E., McQuay, L. J., Atsma, W. J., Franks, B., de Vogel, S., Perez-Gutthann, S., and Arana, A., Value of Free-text Comments for Validating Cancer Cases Using Primary-care Data in the United Kingdom, Epidemiology, vol. 29, pp. e41-e42, 2018.
R. D. Mann, The VAMP system and the detection of risk, some examples, Pharmacoepidemiology and Drug Safety, vol. 3, pp. 313-319, 1994.
D. Gunnell, Irvine, D., Wise, L., Davies, C., and Martin, R. M., Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database, Bmj, vol. 339, p. b3805, 2009.
D. Henry, Lim, L. L., Rodriguez, L. A. Garcia, S. Gutthann, P., Carson, J. L., Griffin, M., Savage, R., Logan, R., Moride, Y., Hawkey, C., Hill, S., and Fries, J. T., Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis, Bmj, vol. 312, pp. 1563-6, 1996.
R. Boggon, Hubbard, R., Smeeth, L., Gulliford, M., Cassell, J., Eaton, S., Pirmohamed, M., and van Staa, T. P., Variability of antibiotic prescribing in patients with chronic obstructive pulmonary disease exacerbations: a cohort study, BMC Pulm Med, vol. 13, p. 32, 2013.
A. Arana, Margulis, A. V., McQuay, L. J., Ziemiecki, R., Bartsch, J. L., Rothman, K. J., Franks, B., D'Silva, M., Appenteng, K., Varas-Lorenzo, C., and Perez-Gutthann, S., Variation in Cardiovascular Risk Related to Individual Antimuscarinic Drugs Used to Treat Overactive Bladder: A UK Cohort Study, Pharmacotherapy, vol. 38, pp. 628-637, 2018.
D. J. Humes, Walker, A. J., Blackwell, J., Hunt, B. J., and West, J., Variation in the risk of venous thromboembolism following colectomy, Br J Surg, vol. 102, pp. 1629-38, 2015.
A. J. Walker, West, J., Card, T. R., Humes, D. J., and Grainge, M. J., Variation in the risk of venous thromboembolism in people with colorectal cancer: a population-based cohort study from England, J Thromb Haemost, vol. 12, pp. 641-9, 2014.
M. Ashworth, Charlton, J., Ballard, K., Latinovic, R., and Gulliford, M., Variations in antibiotic prescribing and consultation rates for acute respiratory infection in UK general practices 1995-2000, Br J Gen Pract, vol. 55, pp. 603-8, 2005.
D. J. Margolis, Bilker, W., Santanna, J., and Baumgarten, M., Venous leg ulcer: incidence and prevalence in the elderly, J Am Acad Dermatol, vol. 46, pp. 381-6, 2002.
R. Lawrenson and Farmer, R., Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference?, Contraception, vol. 62, p. 21S-28S; discussion 37S-38S, 2000.
H. E. Seaman, Langley, S. E., Farmer, R. D., and de Vries, C. S., Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database, BJU Int, vol. 99, pp. 1398-403, 2007.
U. T. Khan, Walker, A. J., Baig, S., Card, T. R., Kirwan, C. C., and Grainge, M. J., Venous thromboembolism and mortality in breast cancer: cohort study with systematic review and meta-analysis, BMC Cancer, vol. 17, p. 747, 2017.
H. E. Seaman, de Vries, C. S., and Farmer, R. D., Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database, Pharmacoepidemiol Drug Saf, vol. 13, pp. 427-36, 2004.
I. Little, Vinogradova, Y., Orton, E., Kai, J., and Qureshi, N., Venous thromboembolism in adults screened for sickle cell trait: a population-based cohort study with nested case-control analysis, BMJ Open, vol. 7, p. e012665, 2017.
A. A. Sultan, Muller, S., Whittle, R., Roddy, E., Mallen, C., and Clarson, L., Venous thromboembolism in patients with gout and the impact of hospital admission, disease duration and urate-lowering therapy, Cmaj, vol. 191, pp. E597-e603, 2019.
C. Renoux, Dell'Aniello, S., Khairy, P., Marras, C., Bugden, S., Turin, T. C., Blais, L., Tamim, H., Evans, C., Steele, R., Dormuth, C., and Ernst, P., Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease, Br J Clin Pharmacol, vol. 82, pp. 461-72, 2016.
W
L. Watson, Wilson, B. P., Alsop, J., and Kumar, S., Weight and glycaemic control in type 2 diabetes: what is the outcome of insulin initiation?, Diabetes Obes Metab, vol. 13, pp. 823-31, 2011.
A. M. Mueller, Meier, C. R., Jick, S. S., and Schneider, C., Weight change and blood glucose concentration as markers for pancreatic cancer in subjects with new-onset diabetes mellitus: A matched case-control study, Pancreatology, 2019.
B. T. Blak, Rigney, U., Sternhufvud, C., Davis, J., and Hammar, N., Weight change and healthcare resource use in English patients with type 2 diabetes mellitus initiating a new diabetes medication class, Int J Clin Pract, vol. 70, pp. 45-55, 2016.
N. M. Davies, Taylor, G., Taylor, A. E., Thomas, K. H., Windmeijer, F., Martin, R. M., and Munafo, M. R., What are the effects of varenicline compared with nicotine replacement therapy on long-term smoking cessation and clinically important outcomes? Protocol for a prospective cohort study, BMJ Open, vol. 5, p. e009665, 2015.
D. Kernick, Stapley, S., Campbell, J., and Hamilton, W., What happens to new-onset headache in children that present to primary care? A case-cohort study using electronic primary care records, Cephalalgia, vol. 29, pp. 1311-6, 2009.
G. E. Smith, Smith, S., Heatlie, H., Bashford, J. N., Hawker, J., Ashcroft, D., Millson, D., Verlander, N. Q., and Warren, R., What has happened to antimicrobial usage in primary care in the United Kingdom since the SMAC report? - description of trends in antimicrobial usage using the General Practice Research Database, J Public Health (Oxf), vol. 26, pp. 359-64, 2004.
T. P. van Staa, Smeeth, L., Persson, I., Parkinson, J., and Leufkens, H. G., What is the harm-benefit ratio of Cox-2 inhibitors?, Int J Epidemiol, vol. 37, pp. 405-13, 2008.
V. M. Walker, Davies, N. M., Kehoe, P. G., and Martin, R. M., What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink, Alzheimers Res Ther, vol. 10, p. 51, 2018.
C. Broadhurst, Rhodes, A. M. L., Harper, P., Perry, D. C., Clarke, N. M. P., and Aarvold, A., What is the incidence of late detection of developmental dysplasia of the hip in England?, Bone Joint J, vol. 101-b, pp. 281-287, 2019.
S. Mukherjee, Culliford, D., Arden, N., and Edwards, C., What is the risk of having a total hip or knee replacement for patients with lupus?, Lupus, vol. 24, pp. 198-202, 2015.
C. L. Morgan, Poole, C. D., Evans, M., Barnett, A. H., Jenkins-Jones, S., and Currie, C. J., What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes, J Clin Endocrinol Metab, vol. 97, pp. 4605-12, 2012.
A. P. McGovern, Dennis, J. M., Shields, B. M., Hattersley, A. T., Pearson, E. R., and Jones, A. G., What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study, BMC Med, vol. 17, p. 79, 2019.
A. J. Walker, West, J., Card, T. R., Crooks, C., Kirwan, C. C., and Grainge, M. J., When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data, Blood, vol. 127, pp. 849-57; quiz 953, 2016.
T. P. Chu, Shah, A., Walker, D., and Coleman, M. P., Where are the opportunities for an earlier diagnosis of primary intracranial tumours in children and young adults?, Eur J Paediatr Neurol, vol. 21, pp. 388-395, 2017.
J. C. Robson, Kiran, A., Maskell, J., Hutchings, A., Arden, N., Dasgupta, B., Hamilton, W., Emin, A., Culliford, D., and Luqmani, R., Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study, J Rheumatol, vol. 43, pp. 1085-92, 2016.
C. C. Yang, Jick, S. S., and Testa, M. A., Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation, Br J Clin Pharmacol, vol. 55, pp. 288-98, 2003.
J. N. Bashford, Norwood, J., and Chapman, S. R., Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database, Bmj, vol. 317, pp. 452-6, 1998.
M. Ashworth, Latinovic, R., Charlton, J., Cox, K., Rowlands, G., and Gulliford, M., Why has antibiotic prescribing for respiratory illness declined in primary care? A longitudinal study using the General Practice Research Database, J Public Health (Oxf), vol. 26, pp. 268-74, 2004.
E. Kontopantelis, Springate, D., Reeves, D., Ashcroft, D. M., Valderas, J. M., and Doran, T., Withdrawing performance indicators: retrospective analysis of general practice performance under UK Quality and Outcomes Framework, Bmj, vol. 348, p. g330, 2014.
C. Gilbert, Allgar, V., and Doran, T., Workload impact of the Quality and Outcomes Framework for patients with diabetes: an interrupted time series in general practice, Br J Gen Pract, vol. 69, pp. e570-e577, 2019.
[Page last reviewed 5 August 2019]